Important announcement for FreeStyle LibreLink app users.

Make sure you are running the latest FreeStyle LibreLink app – version 2.12.0. 
Having the latest app is key to getting the best performance.

Learn More >

ADC-109380 v1.0

Now is the time to move to the FreeStyle Libre 2 Plus sensor

Do you currently wear a FreeStyle Libre 2 sensor?
The FreeStyle Libre 2 sensor will be discontinued in the UK end of August 2025.
Speak to your healthcare professional to get your prescription updated to the FreeStyle Libre 2 Plus sensor.

Find out how to switch >

ADC-104300 v1.0 11/24

Login
My Account
Free Trial
My Account
Checkout
PayPal Logo
American Express Logo
Maestro Logo
Visa Logo
Mastercard Logo
Google Pay Logo
Apple Pay Logo

30 day 100% money back guarantee on your first Starter Kit (Terms and conditions apply)

money-refund

GB Mainland: 3 day delivery
Northern Ireland: 3-4 day delivery
(Estimated standard delivery)

delivery

All payments are secure and encrypted

safe

Your cart is empty

Real-World Evidence

The FreeStyle Libre Portfolio is proven to result in better clinical outcomes for people with diabetes:

  • Reduces hypoglycaemia1,2
  • Decreases HbA1c3,4
  • Increases Time in Range in people with T1D3
  • Improves quality of life3,5
Women with coffee smiling while the FreeStyle Libre sensor is visibile on the back of her arm.
Women with coffee smiling while the FreeStyle Libre sensor is visibile on the back of her arm.
Women with coffee smiling while the FreeStyle Libre sensor is visibile on the back of her arm.

The FreeStyle Libre systems* significantly reduce hypoglycaemia in people with both Type 11
and Type 22 diabetes

An infographic showing that FreeStyle Libre users with Type 1 diabetes saw a 40% reduction in nocturnal hypoglycaemia and a 50% reduction in serious hypoglycaemia.
An infographic showing that FreeStyle Libre users with Type 2 diabetes saw a 54% reduction in nocturnal hypoglycaemia and a 53% reduction in serious hypoglycaemia.

The FreeStyle Libre systems* significantly decrease HbA1c for people with Type 1 diabetes3

An independent study published in the New England Journal of Medicine3 shows that the FreeStyle Libre 2 system reduce HbA1c by 0.5% compared to self-monitored blood glucose (SMBG) at 6 months of use.

Reduced HbA1c chart

The FreeStyle Libre systems** increase %TIR for people with Type 1 diabetes

FreeStyle Libre 2 users spent 2.2 hours more in range per day3

An independent study published in the New England Journal of Medicine shows that FreeStyle Libre 2 users increased their Time in Range by over 2 hours per day:3

  • 156 people with T1D ≥16 years with HbA1c ≥7.5% participated in a randomised, controlled study

  • FreeStyle Libre 2 users spent 2.2 hours more time in range per day at 6 months of use vs those using self-monitored blood glucose (SMBG)
Increased time chart

Making glucose monitoring easy2 for everyone

Discover how the FreeStyle Libre portfolio of products and apps can help manage glucose levels with ease and confidence.5

FreeStyle Libre Portfolio
freestyle for every need
Making glucose monitoring easy2 for everyone
Making glucose monitoring easy2 for everyone
Making glucose monitoring easy2 for everyone
References & Disclaimers 
 

* FreeStyle Libre systems refers to the FreeStyle Libre 2 and FreeStyle Libre 3 systems. The data from these studies was collected using the FreeStyle Libre system and the FreeStyle Libre 2 system. FreeStyle Libre 3 system has the same features as the FreeStyle Libre 2 system therefore the study data is applicable to both products.

1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.

2. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1): 55-73.

3. Leelarathna, L. N Engl J Med. (2022): DOI: 10.1056/NEJMoa2205650.

4. Yaron, M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166

5. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019. https://doi:10.1136/bmjdrc-2019-000809.

Discover
Products
Getting started
MyFreeStyle
Support
Abbott Logo

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorisation of Abbott Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United Kingdom. The product images are for illustrative purposes only.

©️ 2025 Abbott Laboratories Limited. All rights reserved.

Registered Number: 329102 England. Registered Office: Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE

Do you want to leave this page?

The “Yes” link below will take you to a website other than Abbott Laboratories. Links pointing you to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or other links contained on such website. Abbott Laboratories provides these links only as a courtesy and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.

Do you want to leave this page?

Disclaimer

FreeStyle.abbott/uk-en is a product specific website only intended for residents of the United Kingdom. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence.